ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L01EA04 | B | Bosutinib - 400mg | 9911/388 | 60619/1 | BOSULIF | 400mg | 28 | Tablet, film coated | Oral | Droguerie Fattal S.A.L. | Pfizer Manufacturing Deutschland GmbH | Germany | L.L | 2.44 | E2 | Pfizer Europe MA EEIG | Belgium | 05/02/20 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L01EA04 | B | Bosutinib - 400mg | 9911 | 60619/1 | BOSULIF | 400mg | 28 | Tablet, film coated | Oral | Droguerie Fattal S.A.L. | Pfizer Manufacturing Deutschland GmbH | Germany | 239,947,197 L.L | 2.44 | E2 | Pfizer Europe MA EEIG | Belgium | 12/12/20 | 0 |